Our colleagues in the International Bureau for Epilepsy (IBE) have launched a new survey focussing on pregnancy & epilepsy.
The survey is the first of its kind in Europe and through the responses received, the IBE are aiming to understand how well informed women with epilepsy are regarding the risks involved in pregnancy in epilepsy.
A new research project from the University College Dublin School of Psychology - in collaboration with Dún Laoghaire-Rathdown Children's and Young Peoples' Services
In their latest meeting, members of Wexford County Council passed a motion supporting the issue of Free Travel for People with Epilepsy and for Reasonable Accommodations for students with epilepsy who may have a seizure during state examinations.
We are delighted to announce that we have approved research funding for a new study which will investigate the societal impact for people with epilepsy of losing a driving license. The research will take place at FutureNeuro, led by Prof. Norman Delanty; Consultant Neurologist at Beaumont Hospital and Registrar Dr. Stephen Klaus.
The European Commission has approved the use of a new drug as an add-on therapy for the treatment of Dravet Syndrome in patients 2 years and older.
The Commission’s approval of FINTEPLA (Fenfluramine) will mean that the drug’s manufacturers can now apply to European member states regulatory authorities to make the drug available and/or reimbursed in that country.
- Nearly half of the Irish population admit to having little to no knowledge of epilepsy -
As part of the lead up to #EpilepsyDay, we commissioned a survey of 1,000 members of the general public on their understanding, knowledge & attitudes towards epilepsy.
The survey was conducted online between the 13th - 17th January and received a full compliment of 1,000 responses.
The key findings of our survey are as follows:
A new review published in the UK has investigated the use of several common anti-epilepsy drugs (AEDs) during pregnancy.
We are delighted to have been listed as a local patient partner in the development of a National Public & Patient Involvement (PPI) Network.
A new study recently featured in medical journal, The Lancet Neurology, has reported that seizure activity for people with focal epilepsy could be predicted up to day or more in advance of a seizure.